Event Registration
No Image Available

Registrant Information

*First Name:
*Last Name:
*Email:
*Phone Number:

Contact Information

*Address1:
Address2:
*City:
*State:
*Zip Code:
*I am a:
*How did you hear about the program?
Attending Guests†:
First Name
Last Name
Action
No Guests have been added

†To accommodate your guests properly, please provide information here.

Please note that all attendees must be 12 years of age or older,
as well as an HAE patient or caregiver, to attend this program.

By submitting this form, I certify that I am a US resident 18 years of age or older and agree to receiving further communications, including marketing communications, from BioCryst. By registering for the program, I agree that BioCryst (including its representatives and vendors) may use my personal information provided above for data analysis to determine if I am prescribed BioCryst products, to measure the effectiveness of the program, and to contact me for marketing purposes related to BioCryst products and services. I understand that any personally identifying information I provide will be used and protected in accordance with the Terms of Use and Privacy Policy.

By checking this box, I am providing permission for BioCryst to contact my healthcare professional to discuss my health condition and BioCryst products that may treat my condition.(Optional)
Name of my doctor:
*Required field (Enter N/A if not applicable)
 
CAPRI | Sign4compliance Comprehensive Medical Meeting Management System
Powered by:CapriMeetingManager.com
Sign4Compliance.com
Copyright 2024 Blue Grotto Technologies, Inc.
BioCryst and ORLADEYO are registered trademarks of BioCryst Pharmaceuticals, Inc.
©2024 BioCryst Pharmaceuticals, Inc. All rights reserved.

These programs are intended to provide information about the first-ever oral prophylactic therapy for people living with hereditary angioedema (HAE).
Managed by:

Privacy Policy

US.ORL.02417 12/24

WHAT IS ORLADEYO® (berotralstat)?

ORLADEYO (or-luh-DAY-oh) is a prescription medicine used to prevent attacks of hereditary angioedema (HAE) in adults and children 12 years of age and older. It is not known if ORLADEYO is safe and effective in children under 12 years of age.

It is not known if ORLADEYO is safe and effective to treat an acute HAE attack, therefore ORLADEYO should not be used to treat an acute HAE attack.

Do not take more than one capsule of ORLADEYO per day because extra doses can cause heart rhythm problems.

IMPORTANT SAFETY INFORMATION

Before taking ORLADEYO, tell your healthcare provider about all of your medical conditions, including if you

  • have liver problems or are on kidney dialysis.
  • are pregnant or planning to become pregnant. It is not known if ORLADEYO can harm your unborn baby.
  • are breastfeeding or plan to breastfeed. It is not known if ORLADEYO passes into your breastmilk. Talk to your healthcare provider about the best way to feed your baby while taking ORLADEYO.

Tell your healthcare provider about all of the medicines you take, including other medicines for HAE, prescription and over-the-counter medicines, vitamins, and herbal supplements. Taking ORLADEYO with certain other medicines may affect the way other medicines work and other medicines may affect how ORLADEYO works.

Know the medicines you take and keep a list of them to show your healthcare provider and pharmacist when you get a new medicine.

What are the possible side effects of ORLADEYO?
Taking more than one capsule of ORLADEYO per day may cause serious side effects, including heart rhythm problems. A heart rhythm problem called QT prolongation can happen in people who take more than one capsule of ORLADEYO per day. This condition can cause an abnormal heartbeat. Do not take more than one capsule of ORLADEYO per day.

The most common side effects of ORLADEYO include abdominal pain, vomiting, diarrhea, back pain, and heartburn. These are not all of the possible side effects of ORLADEYO. For more information, ask your healthcare provider or pharmacist.

Talk to your healthcare provider for medical advice about side effects.

You are encouraged to report side effects of prescription drugs to BioCryst Pharmaceuticals, Inc at 1-833-633-2279 or to the FDA at www.fda.gov/medwatch or 1-800-FDA-1088.

For more information, please see the full Prescribing Information including the Patient Information.